相关实验视频

Updated: Jun 4, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

由FcRn引导的抗原贩运增强了癌症疫苗的疗效

Mengyu Hong¹, Muziying Liu², Fang Zhu²

¹Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, People's Republic of China.

Cancer immunology, immunotherapy : CII

|January 3, 2025

概括

这项研究介绍了一种新的mRNA疫苗平台,可以增强瘤抗原的呈现. 通过将抗原与新生儿Fc受体 (FcRn) 融合,疫苗可以改善T细胞的反应,并抑制小鼠的瘤生长.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗开发疫苗开发

背景情况:

瘤疫苗在癌症治疗中至关重要,但抗原呈现效率往往低于最佳.
有效的抗原呈现是引起强大的抗瘤免疫反应的关键.

研究的目的:

开发一种创新的mRNA-脂质纳米粒子平台,以提高瘤疫苗的疗效.
为了增强抗原呈现和T细胞对瘤的反应.

主要方法:

一个mRNA-脂质纳米粒子平台被设计为表达与新生儿Fc受体 (FcRn) 融合的瘤抗原表位.
融合利用了FcRn贩运信号来指导表位,以增强MHC类I和II的呈现.
临床前小鼠模型被用于评估瘤生长抑制和生存率.

主要成果:

这种新的平台成功地产生了引起向CD4+和CD8+T细胞反应的表位.
FcRn导向的表位表现显著增强了MHC类I和II抗原表现.
在临床前模型中,疫苗策略导致了显著的瘤生长抑制和延长生存时间.

结论:

将FcRn贩运信号纳入疫苗设计显著提高T细胞反应.
这种新的策略显示出在提高瘤疫苗疗效方面显著的前景.
该平台为癌症免疫治疗提供了潜在的新途径.

关键词:

抗原呈现方式在FcRnnn中.在T细胞表观上,T细胞的表观.瘤是一个瘤.这是mRNA疫苗.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...